Literature DB >> 16255265

Hepatitis C: tackling the silent epidemic.

Adrian N Hamlyn1.   

Abstract

Chronic hepatitis C virus infection is responsible for a significant and growing burden on NHS services. It is one of the commonest causes of liver cirrhosis and hepatocellular carcinoma, and the leading indication for liver transplantation. Major advances have been made in treatment, which can eradicate the virus in more than 50% of patients and reduce complications, but progress is hampered by inadequate detection and access to treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16255265     DOI: 10.12968/hmed.2005.66.10.19897

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN: 1750-8460            Impact factor:   0.825


  1 in total

1.  Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt.

Authors:  Naglaa F A Youssef; Mohamed El Kassas; Amany Farag; Ashley Shepherd
Journal:  BMC Gastroenterol       Date:  2017-01-21       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.